Antibiogram of Bacteria Isolated from Patients with Lower Respiratory Tract Infection at the general outpatient department of some hospitals in Kebbi State, Nigeria

Zaharaddin M. Kalgo; Binta M. Amin; Bashir Muhammed; Habeeb K. Saka

doi:10.54034/mic.e1549

Authors

Zaharaddin M. Kalgo Department of Microbiology, Faculty of Science, Federal University Birnin Kebbi, Kebbi State, Nigeria https://orcid.org/0000-0002-4754-7041
Binta M. Amin Department of Microbiology, Faculty of life Science, Bayero University Kano, Kano State, Nigeria
Bashir Muhammed Department of Microbiology, Faculty of life Science, Bayero University Kano, Kano State, Nigeria
Habeeb K. Saka Crops Research Department, Nigerian Stored Products Research Institute Kano, Kano State Nigeria

DOI:

https://doi.org/10.54034/mic.e1549

Keywords:

antibiotics, susceptibility, pathogens, lower respiratory tract, resistance

Abstract

The rise in antibiotic resistance could be a growing public health concern among agents of respiratory tract infection, which is liable for morbidity, mortality, and costs in Africa. This study was designed to determine the antimicrobial susceptibility pattern of bacteria isolated from patients with lower respiratory tract infection (LRTI) attending some Kebbi State, Nigeria hospitals. Three hundred and fifty sputum samples were collected from consented patients with the symptoms of LRTI attending six different hospitals in Kebbi State. The samples were all screened for significant bacterial growth using standard microbiological techniques. The bacterial isolates were identified using conventional biochemical tests and then confirmed using a commercial biochemical test kit (MICROBACT) according to the manufacturer's instructions. Antimicrobial susceptibility tests were identified using the disc diffusion method. Staphylococcus aureus was the foremost predominant bacteria isolated, followed by Klebsiella pneumoniae, with an estimated percentage occurrence of 31.1% and 22.2%, respectively. Other bacteria isolated include Klebsiella oxytoca (13.9%), Escherichia coli (11.1%), Pseudomonas aeruginosa (5.6%), Aeromonas hydrophila (5.6%), Acinetobacter baumannii (4.6%), B. pseudomallei (2.8%) and Proteus spp (2.8%). Most of the isolates were ssusceptible to piperacilin (51%), trimethoprim-sulfamethoxazole (61%), Azithromycin (70%), Ciprofloxacin (71%) and Gentamycin (74%), so as of ranking. High resistance was recorded in βeta-lactam antibiotics, erythromycin and vancomycin tested. Finally, it was revealed that Staphylococcus aureus is the most predominant bacteria isolated. Most of the isolates were resistant to the β-lactam antibiotic tested. Azithromycin, Ciprofloxacin, Gentamycin, and piperacillin remain helpful antibiotics for treating LRTIs in these centers.

References

Ventola, C. L. The antibiotic resistance crisis: part 1: causes and threats. Pharmacy and Therapeutics 2015; 40(4): 277–83.

Zhang, X., Wang, R., Di, X., Liu, B., Liu, Y. Different microbiological and clinical aspects of lower respiratory tract infections between China and European/ American countries. J Thorac Dis. 2014; 6(2):134–42.

Felmingham, D. Comparative antimicrobial susceptibility of respiratory tract pathogens. Chemotherapy. 2004; 50:3–10.

Adam, H. J., Baxter, M. R., Davidson, R. J., Rubinstein, E., Fanella, S. Canadian antimicrobial resistance a: comparison of pathogens and their antimicrobial resistance. J Antimicrob Chemother 2013; 1:(3)1-7.

Naoya, M. and Yasuhiro, Y. Bacterial Pneumonia in Elderly Japanese Populations. Japanese Clinical Medicine. 2018; 9: 1–4.

Shah, B. A., Singh, G., Naik, M. A. and Dhobi, G. N. Bacteriological and clinical profile of community acquired pneumonia in hospitalized patients. Lung India 2010; 27: 54-57.

Jonaidi, J, N., Ranjbar, R., Haghi-Ashtiani, M.T., Abedini. N., Izadi, M. The study of prevalence and antimicrobial susceptibility of tracheal bacterial strains isolated from paediatric patients. Pakistan Journal of Biological Sciences 2009; 12(5): 455-458

WHO. Antimicrobial resistance: no action today, no cure tomorrow, World Health Day- 7 April, 2012.

Aly, M., Balkhy, A. H. The prevalence of antimicrobial resistance in clinical isolates from gulf corporation council countries. Antimicrobial resistance and infection control. 2012; I:26

Temesgen, D., Bereded, F., Derbie, A., Biadglegne, F. Bacteriology of community acquired pneumonia in adult patients at Felege Hiwot Referral Hospital, Northwest Ethiopia: a cross-sectional study. Antimicrobial Resistance Infection Control. 2019; 8(1):101.

Ashby, B., and Turkington, C. The encyclopaedia of infectious diseases. 3rd Edition, New York. Symptoms of lower respiratory tract infection (LRTI). P. 242

Borkot, U., Sohel, A., Masum, S. and Saquiba Y. Current Trend of Antibiotic Resistance in Lower Respiratory Tract Infections (LRTIs): An Experience in a Teaching Hospital in Bangladesh. Bangladesh Pharmaceutical Journal 2016; 19(1): 85-91

CLSI. Performance standards for antimicrobial susceptibility testing CLSI supplement M100S Wayne 2017; vol. 39. 29th ed.

Lalitha, M. K. Manual on Antimicrobial Susceptibility Testing; Department of Microbiology, Christian Medical College, Vellore, Tamil Nadu. 2006; Pp: 10-13.

Uskudar, G. A., Kocak, A. A., Ok, M. A., Tutluoglu, B., Basustaoglu, A. Antibacterial Resistance in Lower Respiratory Tract Bacterial Pathogens: A Multicenter Analysis from Turkey. Infect Dev Ctries. 2021; 15(2):254-262. doi:10.3855/jidc.12599

Tchatchouang, S., Nzouankeu, A., Kenmoe, S., Ngando, L., Penlap, V., Fonkoua, M. C., Pefura-Yone, E. W., Njouom, R. Bacterial Aetiologies of Lower RespiratoryTract Infections among Adults in Yaoundé, Cameroon. BioMed research international. 2019 Article ID 4834396. https://doi.org/10.1155/2019/4834396

Abdullahi, N, Iregbu, K. C. Antibiogram of bacterial agents of lower respiratory tract infections in a central Nigerian hospital. NigerJ med 2018; 27(1): 29-34

Kalgo, M. Z., Nwabuisi, C., Manga, S. S. Bacterial Pathogens of Lower Respiratory Tract in University of Ilorin Teaching Hospital, Ilorin, Nigeria. International Journal of Innovative Studies in Sciences and Engineering Technology 2016; (2): 2455-4863.

Christopher A. E., Casimir, N. and Richard, O. Microbiology of Lower Respiratory Tract Infections in Benin City, Nigeria. Malaysian J Med Sci. 2010; 18(2): 27-31

Taura, D. W., Hassan, A., Yayo, A. M., Takalmawa, H. Bacterial isolates of the respiratory tract infection and their current sensitivity pattern among patients attending Aminu Kano Teaching Hospital Kano-Nigeria. Int. Res. J. Microbiol. 2013; 4(9):226-231.

Rakshya, N., Basudha, S., Deepak, M. J., Rajesh D. J., Sanjit, S. and Anjana S. Antibiotic Susceptibility Pattern of Gram-negative Isolates of Lower Respiratory Tract Infection. J Nepal Health Res Counc. 2018; 16(38):22-6

Ieven, M. , Coenen, S., Loens, K., Lammens, C., Coenjaerts, F., Vanderstraeten , A., Henriques-Normark , B., D. Crook , D., Huygen , K. Aetiology of lower respiratory tract infection in adults in primary care: a prospective study in 11 European countries. Clinical Microbiology and Infection. 2018; 24: 1158-1163

Pengcheng, L., Menghua, X., Leiyan, H., Liyun, S., Aimin, W., Pan F., Lijuan L., Chuanqing W., and Jin X. Epidemiology of Respiratory Pathogens in Children with Lower Respiratory Tract Infections in Shanghai, China, from 2013 to 2015. Jpn. J. Infect. Dis. 2018; 71, 39–44.

Guclu, A. U., K., Ok, M. A., Tutluoglu, B., Basustaoglu, A. C. Antibacterial Resistance in Lower Respiratory Tract Bacterial Pathogens: A Multicenter Analysis from Turkey. J Infect Dev Ctries. 2021; 7;15(2):254-262. doi: 10.3855/ jidc.12599

Dessie, T., Jemal, M.., Maru, M., Tiruneh, M. Multiresistant Bacterial Pathogens Causing Bacterial Pneumonia and Analyses of Potential Risk Factors from Northeast Ethiopia. International Journal of Microbiology. 2021. Article ID 6680343, https://doi.org/10.1155/2021/6680343

Gebre A. B., Begashaw, T. A., Ormago, M. D. Bacterial Profile and Drug Susceptibility among Adult Patients with Community Acquired Lower Respiratory Tract Infection at Tertiary Hospital, Southern Ethiopia BMC Infect Dis 2021; 13;21(1):440. doi: 10.1186/s12879-021-06151-2.

El-mahmood, H. I., Mohammed, A., and Tirmidhi, A. B. Antimicrobial susceptibility of some respiratory tract pathogens to commonly used antibiotics at the specials hospital, Yola, Adamawa State, Nigeria. J. Clin. Med Res. 2010; 2 (8) 135-142.

Onaolapo, J. A., Olayinka, B. O., Adeshina, G. O., Igwe, J. C., and Obajuluwa, A. F. Antimicrobial Susceptibility Pattern of Staphylococcus aureus Isolates from Orthopaedic Patients in Abuth, Zaria. J Food Ind Microbiol 2016; 2:1

Abayomi, S. A., Adegboro, B., and Taiwo, S. S. Laboratory survey of extended spectrum beta-lactamase producing enterobacteriaceae in clinical infections among hospitalised patients at LAUTECH Teaching Hospital, Ogbomoso, Nigeria Afr. J. Clin. Exper. Microbiol. 2020; 21 (1): 66 – 71

Sriramulu D. Evolution and impact of bacterial drug resistance in the context of cystic fibrosis disease and nosocomial settings. Microbiol Insights. 2013; 6:29–36.

Atkin, S. D., Abid, S., Foster, M., Bose, M., Keller, A., Rita Hollaway, K. R., Sader, H. S. Multidrug-resistant Pseudomonas aeruginosa from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime–avibactam. Infection and Drug Resistance. 2018; 11:1499–1510 http://dx.doi.org/10.2147/IDR.S173804

Limmathurotsakul, N., Golding, N., David AB Dance, A. B. D., Messina, P. J., Pigott, M. D., Moyes, L. C., Rolim, B. D., Bertherat, E., Day, P. J. N., Sharon J Peacock, J. S., and Hay, I. S.N Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat Microbiol. 2016; 1(1): . doi:10.1038/nmicrobiol.2015.8.

Limmathurotsakul, D., Wongratanacheewin, S., Teerawattanasook, N., Wongsuvan, G., Chaisuksant, S., Chetchotisakd, P., Chaowagul, W., Day, P. J. N., anD Peacock, J. S. Increasing Incidence of Human Melioidosis in Northeast Thailand. Am. J. Trop. Med. Hyg., 82(6), 2010, pp. 1113–1117 doi:10.4269/ajtmh.2010.10-0038

Currie BJ, Ward L, Cheng AC. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl Trop Dis. 2010; 4:e900.

Limmathurotsakul D, Kanoksil M, Wuthiekanun V, Kitphati R, deStavola B, Day NP, Peacock SJ. 2013. Activities of daily living associated with acquisition of melioidosis in northeast Thailand: a matched case-control study. PLoS Negl Trop Dis 7:e2072. https://doi.org/10.1371/journal.pntd.0002072.

Wiersinga, W., Bonten, M. J., Boersma, W. G. “Management of community-acquired pneumonia in adults: 2016 guideline update from the Dutch working party on antibiotic policy (SWAB) and Dutch association of chest physicians (NVALT),” Netherlands Journal of Medicine 2018, 76(1): 4–13.

Chao, C. M., Lai, C. C., Tsai, H. Y., Wu, C. J., Tang, H. J., Ko, W. C., Hsueh, P. R. Pneumonia caused by Aeromonas species in Taiwan, 2004–2011 Eur J Clin Microbiol Infect Dis. 2013; 32:1069–1075 DOI 10.1007/s10096-013-1852-6

Nagata, K., Takeshima, Y., Tomii, K., Imai, Y. Fulminant fatal bacteremic pneumonia due to Aeromonas hydrophila in a nonimmunocompromised woman. Intern Med 2011; 50:63–65

Ye, Y., Xu, X.H., Li,J.B. EmergenceofCTX-M-3,TEM-1anda new plasmid-mediatedMOX-4AmpCinamultiresistant Aeromonas caviae isolate fromapatientwithpneumonia. J. Med.Microbiol. 2010; 59,843–847.doi: 10.1099/ jmm.0.016337-0

Murata, H., Yoshimoto, H., Masuo, M., Tokuda, H., Kitamura, S. Fulminant pneumonia due to Aeromonas hydrophila in a man with chronic renal failure and liver cirrhosis. Intern Med 2001; 40:118–123